Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland

Multisystem inflammatory syndrome in children (MIS-C) is an immune-mediated complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Cardiovascular system is commonly involved. Acute heart failure (AHF) is the most severe complication of MIS-C, leading to cardiogenic shock. The aim of the study was to characterise the course of MIS-C with a focus on cardiovascular involvement, based on echocardiographic (echo) evaluation, in 498 children (median age 8.3 years, 63% boys) hospitalised in 50 cities in Poland. Among them, 456 (91.5%) had cardiovascular system involvement: 190 (48.2%) of patients had (most commonly atrioventricular) valvular insufficiency, 155 (41.0%) had contractility abnormalities and 132 (35.6%) had decreased left ventricular ejection fraction (LVEF < 55%). Most of these abnormalities improved within a few days. Analysis of the results obtained from two echo descriptions (a median of 5 days apart) revealed a >10% increase in LVEF even in children with primarily normal LVEF. Lower levels of lymphocytes, platelets and sodium and higher levels of inflammatory markers on admission were significantly more common among older children with contractility dysfunction, while younger children developed coronary artery abnormality (CAA) more often. The incidence of ventricular dysfunction might be underestimated. The majority of children with AHF improved significantly within a few days. CAAs were relatively rare. Children with impaired contractility as well as other cardiac abnormalities differed significantly from children without such conditions. Due to the exploratory nature of this study, these findings should be confirmed in further studies.

[1]  A. Šedivá,et al.  Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper , 2023, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[2]  Belma Yaşar,et al.  Cardiac Evaluation in Children with Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 , 2022, Sisli Etfal Hastanesi tip bulteni.

[3]  B. McCrindle,et al.  Differentiation of COVID-19–Associated Multisystem Inflammatory Syndrome From Kawasaki Disease With the Use of Cardiac Biomarkers , 2022, The Canadian Journal of Cardiology.

[4]  T. Kuno,et al.  Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis , 2022, Pediatric Cardiology.

[5]  Michelle R Santoso,et al.  Cardiovascular Magnetic Resonance in Children with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: Institutional Protocol-Based Medium-Term Follow-up Study , 2022, Pediatric Cardiology.

[6]  M. Oster,et al.  Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children , 2022, Journal of the American Heart Association.

[7]  M. Gattorno,et al.  Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age , 2022, Children.

[8]  V. Calcaterra,et al.  Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study , 2022, Italian Journal of Pediatrics.

[9]  A. Boutten,et al.  Multisystem inflammatory syndrome in children: inputs of BNP, NT-proBNP and Galectin-3. , 2022, Clinica chimica acta; international journal of clinical chemistry.

[10]  M. Oster,et al.  Cardiac Magnetic Resonance Findings After Multisystem Inflammatory Syndrome in Children. , 2022, The Journal of pediatrics.

[11]  K. Ludwikowska,et al.  Takotsubo syndrome as a cardiac manifestation of multisystem inflammatory syndrome in children. , 2021, Cardiology in the young.

[12]  M. Zaniew,et al.  Distinct characteristics of multisystem inflammatory syndrome in children in Poland , 2021, Scientific Reports.

[13]  P. Ponikowski,et al.  Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry , 2021, ESC heart failure.

[14]  R. Friedman,et al.  Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children , 2021, Pediatrics.

[15]  Kanwal M. Farooqi,et al.  Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children , 2021, Pediatrics.

[16]  A. Hadash,et al.  Emergency department levels of NT-proBNP and inotropic/vasoactive support in multi-inflammatory syndrome in children (MIS-C) , 2021, The American Journal of Emergency Medicine.

[17]  Manish M Patel,et al.  Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.

[18]  M. Oster,et al.  Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.

[19]  P. Brodin Immune determinants of COVID-19 disease presentation and severity , 2021, Nature Medicine.

[20]  M. Cunningham,et al.  Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment , 2020, Frontiers in Pediatrics.

[21]  D. De Wolf,et al.  Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. , 2020, Circulation.

[22]  C. Newton-Cheh,et al.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[23]  J. Glickstein,et al.  Role of a Pediatric Cardiologist in the COVID-19 Pandemic , 2020, Pediatric Cardiology.

[24]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.

[25]  D. Buonsenso,et al.  Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome , 2020, Frontiers in Pediatrics.

[26]  J. Rossano,et al.  Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States , 2020, Journal of the American College of Cardiology.

[27]  B. Totapally,et al.  Takotsubo cardiomyopathy in children , 2020, Cardiology in the Young.

[28]  A. Piantadosi,et al.  A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report , 2020, BMC Infectious Diseases.

[29]  J. Newburger,et al.  Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.

[30]  K. Reilly,et al.  COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[31]  R. Loomba,et al.  COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise? , 2020, Cureus.

[32]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[33]  P. Ponikowski,et al.  Cardiac emergencies during the COVID-19 pandemic in the light of the current evidence. , 2020, Kardiologia polska.

[34]  P. Palma,et al.  The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 , 2020, Cell.

[35]  P. Davies,et al.  Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.

[36]  D. Thacker Multisystem Inflammatory Syndrome in Children (MIS-C): , 2020, Delaware journal of public health.

[37]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[38]  P. Kahn,et al.  COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult , 2020, The American Journal of Emergency Medicine.

[39]  Jun Ren,et al.  SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management , 2020, Biochemical Pharmacology.

[40]  E. Blondiaux,et al.  Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series , 2020, Radiology.

[41]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[42]  V. Reddy,et al.  Takotsubo Cardiomyopathy in COVID-19 , 2020, Journal of the American College of Cardiology.

[43]  C. Delacourt,et al.  SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[44]  L. Bonnemains,et al.  Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic , 2020, Circulation.

[45]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[46]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[47]  G. Passalacqua,et al.  Takotsubo Syndrome Associated with COVID-19 , 2020, European journal of case reports in internal medicine.

[48]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[49]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[50]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[51]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[52]  Yiwu Zhou,et al.  SARS-CoV-2: a potential novel etiology of fulminant myocarditis , 2020, Herz.

[53]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[54]  M. Biteker,et al.  Takotsubo (stress) cardiomyopathy in childhood , 2019, European Journal of Pediatrics.

[55]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[56]  H. Pan,et al.  Polish 2010 growth references for school-aged children and adolescents , 2010, European Journal of Pediatrics.

[57]  Nagib Dahdah,et al.  New equations and a critical appraisal of coronary artery Z scores in healthy children. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[58]  K. Shadan,et al.  Available online: , 2012 .